Loading clinical trials...
Loading clinical trials...
An Observational Study of Perinatal Outcomes Following Change in Clinical Criteria in for Treatment of Maternal Hypertension
The purpose of this study is observe outcomes before and after a change in clinical practice in the threshold for management of severe hypertension in pregnancy and the post-partum period. Outcomes will be observed for 10 months under the current (traditional) clinical blood pressure threshold for acute treatment of hypertension, which is \>= 160 millimeters of mercury (mmHg) systolic blood pressure (SBP). This will be followed by one month of education about rationale for the new SBP threshold of \>= 180 mmHg and change of clinical guidelines. Then, there will be 10 months of observation after adopting the updated clinical threshold for acute antihypertensive treatment (\>= 180 SBP).
Age
All ages
Sex
FEMALE
Healthy Volunteers
No
UT Houston
Houston, Texas, United States
Start Date
May 11, 2023
Primary Completion Date
April 4, 2024
Completion Date
April 4, 2024
Last Updated
July 28, 2025
1,003
ACTUAL participants
Clinical blood pressure threshold of SBP >= 160 mmHg for acute treatment of hypertension
PROCEDURE
Clinical blood pressure threshold of SBP >= 180 mmHg for acute treatment of hypertension
PROCEDURE
Lead Sponsor
The University of Texas Health Science Center, Houston
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions